Quibim
Boston, United States · Artificial Intelligence, Biotechnology, Health Care · 97 employees
Quibim designs pioneering tools that unlock imaging data to improve patient outcomes. Our main purpose is the application of AI techniques to medical images from MRI, CT, PET to unlock new data which can be transformed into actionable predictions for life sciences and providers.
Funding history
- Series series a — $50.0M — Jan 2025
Recent signals
- Apr 10, 2026: Quibim Appoints Itta MacNevin as Chief Business Officer
- Jan 28, 2025: Raised $50.0M in Series series a
- Jan 28, 2025: Quibim Announces Partnership with Asabys and Buenavista to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers
- May 26, 2023: Quibim, a company leveraging artificial intelligence to improve cancer diagnostics, makes key move into U.S. by hiring Boston-based chief medical officer
See plans & pricing → Track Quibim’s funding, hiring, and signals — with verified contacts — on Fundz.